search
› › › FDA approves first postpartum depression drug. It works quickly but costs over $20K, report says
FDA approves first postpartum depression drug. It works quickly but costs over $20K, report says

FDA approves first postpartum depression drug. It works quickly but costs over $20K, report says

By Wednesday, March 20, 2019 Comment Edit

Brexanolone, sold as Zulresso, is delivered as a continuous IV infusion over 60 hours. It reportedly works quickly and costs $20,000 or more.

     
 
 


from USATODAY - News Top Stories https://ift.tt/2ULMYY2
via IFTTT

Related Posts

0 Response to "FDA approves first postpartum depression drug. It works quickly but costs over $20K, report says"

Post a Comment

Subscribe to: Post Comments (Atom)